216 related articles for article (PubMed ID: 30506016)
1. Stromal Content Is Correlated With Tissue Site, Contrast Retention, and Survival in Pancreatic Adenocarcinoma.
Torphy RJ; Wang Z; True-Yasaki A; Volmar KE; Rashid N; Yeh B; Anderson JM; Johansen JS; Hollingsworth MA; Yeh JJ; Collisson EA
JCO Precis Oncol; 2018; 2018():. PubMed ID: 30506016
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic adenocarcinoma: quantitative CT features are correlated with fibrous stromal fraction and help predict outcome after resection.
Cai X; Gao F; Qi Y; Lan G; Zhang X; Ji R; Xu Y; Liu C; Shi Y
Eur Radiol; 2020 Sep; 30(9):5158-5169. PubMed ID: 32346792
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical FAP Expression Reflects
Spektor AM; Gutjahr E; Lang M; Glatting FM; Hackert T; Pausch T; Tjaden C; Schreckenberger M; Haberkorn U; Röhrich M
J Nucl Med; 2024 Jan; 65(1):52-58. PubMed ID: 38167622
[TBL] [Abstract][Full Text] [Related]
4. The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma.
Wang LM; Silva MA; D'Costa Z; Bockelmann R; Soonawalla Z; Liu S; O'Neill E; Mukherjee S; McKenna WG; Muschel R; Fokas E
Oncotarget; 2016 Jan; 7(4):4183-94. PubMed ID: 26716653
[TBL] [Abstract][Full Text] [Related]
5. Alignment of stroma fibers, microvessel density and immune cell populations determine overall survival in pancreatic cancer-An analysis of stromal morphology.
Bolm L; Zghurskyi P; Lapshyn H; Petrova E; Zemskov S; Vashist YK; Deichmann S; Honselmann KC; Bronsert P; Keck T; Wellner UF
PLoS One; 2020; 15(7):e0234568. PubMed ID: 32658932
[TBL] [Abstract][Full Text] [Related]
6. TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinoma.
Dall'Ora M; Rovesti G; Reggiani Bonetti L; Casari G; Banchelli F; Fabbiani L; Veronesi E; Petrachi T; Magistri P; Di Benedetto F; Spallanzani A; Chiavelli C; Spano MC; Maiorana A; Dominici M; Grisendi G
Am J Cancer Res; 2021; 11(9):4500-4514. PubMed ID: 34659901
[TBL] [Abstract][Full Text] [Related]
7. Generation of an in vitro 3D PDAC stroma rich spheroid model.
Ware MJ; Keshishian V; Law JJ; Ho JC; Favela CA; Rees P; Smith B; Mohammad S; Hwang RF; Rajapakshe K; Coarfa C; Huang S; Edwards DP; Corr SJ; Godin B; Curley SA
Biomaterials; 2016 Nov; 108():129-42. PubMed ID: 27627810
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the stromal contribution to Sonic Hedgehog-dependent pancreatic adenocarcinoma.
Damhofer H; Medema JP; Veenstra VL; Badea L; Popescu I; Roelink H; Bijlsma MF
Mol Oncol; 2013 Dec; 7(6):1031-42. PubMed ID: 23998958
[TBL] [Abstract][Full Text] [Related]
9. Signal enhancement ratio of multi-phase contrast-enhanced MRI: an imaging biomarker for survival in pancreatic adenocarcinoma.
Xia C; Qu JR; Jiao YP; Lu CQ; Zhao B; Ge RJ; Qiu Y; Cao BY; Yu Q; Xia TY; Meng XP; Song Y; Zhang LH; Long XY; Ye J; Ding ZM; Cai W; Ju SH
Eur Radiol; 2024 May; ():. PubMed ID: 38750169
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic Ductal Adenocarcinoma: Interface Enhancement Gradient Measured on Dual-Energy CT Images Improves Prognostic Evaluation.
Amer AM; Li Y; Summerlin D; Burgan CM; McNamara MM; Smith AD; Morgan DE
Radiol Imaging Cancer; 2020 Jul; 2(4):e190074. PubMed ID: 33778722
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronan heterogeneity in pancreatic ductal adenocarcinoma: Primary tumors compared to sites of metastasis.
Placencio-Hickok VR; Lauzon M; Moshayedi N; Guan M; Kim S; Nissen N; Lo S; Pandol S; Larson BK; Gong J; Hendifar AE; Osipov A
Pancreatology; 2022 Jan; 22(1):92-97. PubMed ID: 34657790
[TBL] [Abstract][Full Text] [Related]
12. Diffusion Kurtosis Imaging-A Superior Approach to Assess Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma.
Mayer P; Jiang Y; Kuder TA; Bergmann F; Khristenko E; Steinle V; Kaiser J; Hackert T; Kauczor HU; Klauß M; Gaida MM
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32580519
[TBL] [Abstract][Full Text] [Related]
13. A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma.
Koay EJ; Lee Y; Cristini V; Lowengrub JS; Kang Y; Lucas FAS; Hobbs BP; Ye R; Elganainy D; Almahariq M; Amer AM; Chatterjee D; Yan H; Park PC; Rios Perez MV; Li D; Garg N; Reiss KA; Yu S; Chauhan A; Zaid M; Nikzad N; Wolff RA; Javle M; Varadhachary GR; Shroff RT; Das P; Lee JE; Ferrari M; Maitra A; Taniguchi CM; Kim MP; Crane CH; Katz MH; Wang H; Bhosale P; Tamm EP; Fleming JB
Clin Cancer Res; 2018 Dec; 24(23):5883-5894. PubMed ID: 30082477
[TBL] [Abstract][Full Text] [Related]
14. Visual enhancement pattern during the delayed phase of enhanced CT as an independent prognostic factor in stage IV pancreatic ductal adenocarcinoma.
Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Nagano H; Hidaka S; Kamimura K; Maemura K; Arima S; Yoshiura T
Pancreatology; 2020 Sep; 20(6):1155-1163. PubMed ID: 32800574
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of preoperative [
Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Huo L; Li X
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1780-1791. PubMed ID: 36695823
[TBL] [Abstract][Full Text] [Related]
16. Highly aligned stromal collagen is a negative prognostic factor following pancreatic ductal adenocarcinoma resection.
Drifka CR; Loeffler AG; Mathewson K; Keikhosravi A; Eickhoff JC; Liu Y; Weber SM; Kao WJ; Eliceiri KW
Oncotarget; 2016 Nov; 7(46):76197-76213. PubMed ID: 27776346
[TBL] [Abstract][Full Text] [Related]
17. Preoperative prediction of disease-free survival in pancreatic ductal adenocarcinoma patients after R0 resection using contrast-enhanced CT and CA19-9.
Li D; Peng Q; Wang L; Cai W; Liang M; Liu S; Ma X; Zhao X
Eur Radiol; 2024 Jan; 34(1):509-524. PubMed ID: 37507611
[TBL] [Abstract][Full Text] [Related]
18. Estimating Recurrence after Upfront Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinoma by Using Pancreatic CT: Development and Validation of a Risk Score.
Kim DW; Lee SS; Kim SO; Kim JH; Kim HJ; Byun JH; Yoo C; Kim KP; Song KB; Kim SC
Radiology; 2020 Sep; 296(3):541-551. PubMed ID: 32662759
[TBL] [Abstract][Full Text] [Related]
19. Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.
Nagathihalli NS; Castellanos JA; Shi C; Beesetty Y; Reyzer ML; Caprioli R; Chen X; Walsh AJ; Skala MC; Moses HL; Merchant NB
Gastroenterology; 2015 Dec; 149(7):1932-1943.e9. PubMed ID: 26255562
[TBL] [Abstract][Full Text] [Related]
20. DeepPrognosis: Preoperative prediction of pancreatic cancer survival and surgical margin via comprehensive understanding of dynamic contrast-enhanced CT imaging and tumor-vascular contact parsing.
Yao J; Shi Y; Cao K; Lu L; Lu J; Song Q; Jin G; Xiao J; Hou Y; Zhang L
Med Image Anal; 2021 Oct; 73():102150. PubMed ID: 34303891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
